New Delhi: As the government’s ambitious National Health Protection Scheme (NHPS) under the Ayushman Bharat Yojana completes a year, a whitepaper examines the impact of the scheme that signals a shift in the government’s traditional role in healthcare from being the primary provider to being a payer.
The whitepaper titled ‘India’s National Health Protection Scheme: Ayushman Bharat – Growing Opportunities in Affordable Healthcare’ has been published by SKP – one of India’s leading provider of business consulting services.
NHPS is a major indicator of the government’s assurance to focus on secondary and tertiary healthcare, particularly for sections of the population that do not have easy access. Since its launch, NPHS has covered about 100 million eligible families, offering insurance coverage of ~USD7000 across 1,350 procedures in major therapies. Over 30 states and union territories have been covered so far.
The paper explores different aspects of the scheme with a focus on how NHPS provides the government with a unique opportunity to bring institutional reforms to a sector, where historically, change has been difficult to implement. In a country like India, the penetration of health insurance has been on the lower side for years. However, it has almost doubled between FY 2013-17 across urban and rural India, witnessing an upward trajectory.
The paper lays thrust on the fact that the NHPS offers an important stimulus to the healthcare industry, spiking up growth rates across sectors in the future. It mentions how the Healthcare Delivery sector would be the largest beneficiary by volume, as hospital capacity needs to be built up significantly and rapidly to service the added influx of patients.
Impact of NHPS in numbers
- As of March 2019, NHPS has empaneled close to 15,000 hospitals treating about 6000 patients per day, with an average spend of ~USD 170.
- Expected segment-wise impact on the medical devices industry: Medical Equipment and Furniture to register 33-45% CAGR over the next three years. Medical Consumables and Disposables to register 23-33% CAGR over the next three years.
- Expected impact on the Pharma industry: 15-16% CAGR over the next three years.